← Back
$EDIT All transactions

Editas Medicine, Inc.

▼ SELL

$ Value

$957

Shares

474

Price

$2

Filed

Mar 4

Insider

Name

Parison Amy

Title

SVP, Chief Financial Officer

CIK

0002063082

Roles

Officer

Transaction Details

Transaction Date

2026-03-03

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

15,434

Footnotes

Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2026. The sale does not represent a discretionary trade by the Reporting Person. | This transaction was executed in multiple trades at prices ranging from $2.0050 to $2.0204. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Filing Info

Accession No.

0001650664-26-000007

Form Type

4

Issuer CIK

0001650664

Parison Amy's History

Date Ticker Type Value
2026-03-12 EDIT A $0
2026-03-03 EDIT $957
2025-12-03 EDIT $993
2025-09-03 EDIT $1K
2025-08-07 EDIT $2K
2025-06-03 EDIT $769

Other Insiders at EDIT (90d)

Insider Bought Sold Last
O'Neill Gilmore Neil
CEO
$11K 2026-03-12
Burkly Linda
EVP, CHIEF SCIENTIFIC OFFICER
$2K 2026-03-12
Parison Amy
SVP, Chief Financial Officer
2026-03-12